253 related articles for article (PubMed ID: 23885912)
41. Late emergence of contrast-enhancing fat necrosis mimicking tumor seeding after renal cryoablation.
Durack JC; Richioud B; Lyon J; Solomon SB
J Vasc Interv Radiol; 2014 Jan; 25(1):133-7. PubMed ID: 24365507
[TBL] [Abstract][Full Text] [Related]
42. Percutaneous image-guided renal ablations: Current evidences for long-term oncologic efficacy.
Nouri-Neuville M; Ben Ammar M; Cornelis FH
Presse Med; 2019; 48(7-8 Pt 2):e233-e243. PubMed ID: 31445699
[TBL] [Abstract][Full Text] [Related]
43. Percutaneous radiofrequency ablation of small renal cell carcinoma: technique, complications, and outcomes.
Popovic P; Lukic S; Mijailovic M; Salapura V; Garbajs M; Surlan Popovic K
J BUON; 2012; 17(4):621-6. PubMed ID: 23335516
[TBL] [Abstract][Full Text] [Related]
44. Initial Assessment of the Efficacy of Irreversible Electroporation in the Focal Treatment of Localized Renal Cell Carcinoma With Delayed-interval Kidney Tumor Resection (Irreversible Electroporation of Kidney Tumors Before Partial Nephrectomy [IRENE] Trial-An Ablate-and-Resect Pilot Study).
Wendler JJ; Pech M; Fischbach F; Jürgens J; Friebe B; Baumunk D; Porsch M; Blaschke S; Schindele D; Siedentopf S; Ricke J; Schostak M; Köllermann J; Liehr UB
Urology; 2018 Apr; 114():224-232. PubMed ID: 29305201
[TBL] [Abstract][Full Text] [Related]
45. Radiofrequency ablation of small renal tumors.
Johnson DB; Cadeddu JA
Expert Rev Anticancer Ther; 2004 Feb; 4(1):77-83. PubMed ID: 14748659
[TBL] [Abstract][Full Text] [Related]
46. Sequential changes after radiofrequency ablation and cryoablation of renal neoplasms: role of CT and MR imaging.
Kawamoto S; Permpongkosol S; Bluemke DA; Fishman EK; Solomon SB
Radiographics; 2007; 27(2):343-55. PubMed ID: 17374857
[TBL] [Abstract][Full Text] [Related]
47. Current status of cryoablation and radiofrequency ablation in the management of renal tumors.
Desai MM; Gill IS
Curr Opin Urol; 2002 Sep; 12(5):387-93. PubMed ID: 12172425
[TBL] [Abstract][Full Text] [Related]
48. Thermal Ablation for Renal Cell Carcinoma: Expert Consensus from the Asian Conference on Tumor Ablation.
Park BK; Shen SH; Fujimori M; Wang Y
Korean J Radiol; 2021 Sep; 22(9):1490-1496. PubMed ID: 34448380
[No Abstract] [Full Text] [Related]
49. Novel methods for renal tissue ablation.
Olweny EO; Cadeddu JA
Curr Opin Urol; 2012 Sep; 22(5):379-84. PubMed ID: 22706069
[TBL] [Abstract][Full Text] [Related]
50. Radiofrequency ablation of renal cell carcinoma.
McDougal WS
BJU Int; 2007 May; 99(5 Pt B):1271-2. PubMed ID: 17441922
[No Abstract] [Full Text] [Related]
51. Radiofrequency ablation as an alternative therapy for renal neoplasms in graft recipients. A preliminary study.
Hernández-Socorro CR; Henríquez-Palop F; Santana-Toledo L; Gallego-Samper R; Rodríguez-Pérez JC
Nefrologia; 2015; 35(5):514-6. PubMed ID: 26306951
[No Abstract] [Full Text] [Related]
52. MR imaging follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: findings in 18 patients during first 6 months.
Merkle EM; Nour SG; Lewin JS
Radiology; 2005 Jun; 235(3):1065-71. PubMed ID: 15914485
[TBL] [Abstract][Full Text] [Related]
53. Society of Interventional Radiology Position Statement on the Role of Percutaneous Ablation in Renal Cell Carcinoma: Endorsed by the Canadian Association for Interventional Radiology and the Society of Interventional Oncology.
Morris CS; Baerlocher MO; Dariushnia SR; McLoney ED; Abi-Jaoudeh N; Nelson K; Cura M; Abdel Aal AK; Mitchell JW; Madassery S; Partovi S; McClure TD; Tam AL; Patel S
J Vasc Interv Radiol; 2020 Feb; 31(2):189-194.e3. PubMed ID: 31917025
[No Abstract] [Full Text] [Related]
54. Society of Interventional Radiology Quality Improvement Standards on Percutaneous Ablation in Renal Cell Carcinoma.
Gunn AJ; Parikh NS; Bhatia S
J Vasc Interv Radiol; 2020 Feb; 31(2):195-201.e3. PubMed ID: 31917026
[No Abstract] [Full Text] [Related]
55. Multiple nephron-sparing procedures in solitary kidney with recurrent, metachronous, nonfamilial renal cell carcinoma.
Nosnik IP; Mouraviev V; Nelson R; Polascik TJ
Urology; 2006 Dec; 68(6):1343.e1-3. PubMed ID: 17141824
[TBL] [Abstract][Full Text] [Related]
56. Complications following 573 percutaneous renal radiofrequency and cryoablation procedures.
Atwell TD; Carter RE; Schmit GD; Carr CM; Boorjian SA; Curry TB; Thompson RH; Kurup AN; Weisbrod AJ; Chow GK; Leibovich BC; Callstrom MR; Patterson DE
J Vasc Interv Radiol; 2012 Jan; 23(1):48-54. PubMed ID: 22037491
[TBL] [Abstract][Full Text] [Related]
57. Minimally invasive treatment of renal cell carcinoma: comparison of 4 different monopolar radiofrequency devices.
Häcker A; Vallo S; Weiss C; Grobholz R; Alken P; Knoll T; Michel MS
Eur Urol; 2005 Oct; 48(4):584-92. PubMed ID: 16046053
[TBL] [Abstract][Full Text] [Related]
58. Histologic evaluation of radiofrequency ablation in renal cancer.
Bastide C; Garcia S; Anfossi E; Ragni E; Rossi D
Eur J Surg Oncol; 2006 Nov; 32(9):980-3. PubMed ID: 16952433
[TBL] [Abstract][Full Text] [Related]
59. [Percutaneous local ablation of small renal cell cancer].
Ringe KI
Aktuelle Urol; 2021 Sep; 52(5):445-451. PubMed ID: 33860478
[TBL] [Abstract][Full Text] [Related]
60. Thermal ablation: update and technique at a high-volume institution.
Krehbiel K; Ahmad A; Leyendecker J; Zagoria R
Abdom Imaging; 2008; 33(6):695-706. PubMed ID: 18379836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
